Showing results (11-20 of 313) with videos related to
Sort By:
Pageof 32
Current Opinion in Hematology|February 28, 2008
Potential role of novel nucleoside analogs in the treatment of acute myeloid leukemiaStefan Faderl, Varsha Gandhi, Hagop M KantarjianOncology (Williston Park, N.Y.)|March 18, 1999
Chronic myelogenous leukemia: update on biology and treatmentStefan Faderl, Hagop M Kantarjian, Moshe TalpazExpert Review of Anticancer Therapy|October 6, 2006
Monoclonal antibodies in chronic lymphocytic leukemiaAlessandra Ferrajoli, Stefan Faderl, Michael J KeatingCurrent Hematologic Malignancy Reports|April 29, 2010
New aspects of the treatment of chronic lymphocytic leukemiaStefan Faderl, William Wierda, Michael J KeatingBest Practice & Research. Clinical Haematology|September 26, 2006
Monoclonal antibody combinations in CLL: evolving strategiesStefan Faderl, Susan O'Brien, Michael J KeatingAmerican Journal of Hematology|July 14, 2006
Sweet's syndrome in chronic lymphocytic leukemia associated with neutropenic fever and granulocyte colony stimulation factorMichael A Thompson, Senait W Dyson, Stefan FaderlCurrent Hematologic Malignancy Reports|April 29, 2010
Modern treatment programs for adults with acute lymphoblastic leukemiaFarhad Ravandi, Stefan Faderl, Partow Kebriaei, et al.Mayo Clinic Proceedings|November 22, 2005
Adult acute lymphoblastic leukemiaElias J Jabbour, Stefan Faderl, Hagop M KantarjianClinical Lymphoma, Myeloma & Leukemia|November 6, 2012
Long-term follow-up of patients with hypereosinophilic syndrome treated with Alemtuzumab, an anti-CD52 antibodyPaolo Strati, Jorge Cortes, Stefan Faderl, et al.British Journal of Haematology|June 13, 2002
Time to platelet recovery predicts outcome of patients with de novo acute lymphoblastic leukaemia who have achieved a complete remissionStefan Faderl, Peter F Thall, Hagop M Kantarjian, et al.Pageof 32